References: Filippatos, T
By stimulating both GLP-1 and GIP receptors, tirzepatide effectively reduces appetite, prolongs fullness, enhances insulin sensitivity, and potentially boosts your metabolism
This is the more straightforward approach, but youll need to be ready for your appetite returning within one to two weeks
Patients with renal impairment can generally use semaglutide and tirzepatide without dose adjustment, though monitoring for dehydration from gastrointestinal side effects is important
Part VII: IP Valuation Frameworks The Net Present Value of Patent Protection IP valuation in pharma is ultimately a cash flow problem
continued the medication stopped the medication Patients who stayed on the medication didnt just hold their weight off they continued losing during maintenance, dropping another 5 to 7% to reach 17.4% total weight loss on Wegovy and 25% on Zepbound